Ignite Creation Date:
2024-10-26 @ 3:38 PM
Last Modification Date:
2024-10-26 @ 3:38 PM
Study NCT ID:
NCT06572566
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-22
Brief Title:
Study on Neuropsychiatric Behavior in Cadmium-exposed People
Sponsor:
None
Organization:
None
Study Overview
Official Title:
Study on the Mechanism of Action of Chemical Category 1 Innovative Drug GMDTC on Neuropsychiatric Behavior in Cadmium-exposed People
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study hypothesized that excessive cadmium is related to clinical pain depression and cognitive impairment and that related indicators will improve after cadmium is eliminated
Detailed Description:
This study will combine the research progress of the innovative drug GMDTC the mechanism of nerve damage caused by Cd2 disrupting Ca2 homeostasis imaging technology and analysis methods and the basis of our previous research work to explore the effect of the chemical Class 1 innovative drug GMDTC on the neuropsychiatric behavior of people with excessive cadmium mechanism of action This study is not limited to the study of the mechanism of neurotoxicity after Cd2 deposition It will also clarify the clinical efficacy of the innovative drug GMDTC in removing Cd2 deposition in the brain and reducing damage which is expected to open up new avenues for the treatment of cadmium neurotoxicity This study hypothesized that excessive cadmium is related to clinical pain depression and cognitive impairment and that related indicators will improve after cadmium is eliminated
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None